Background and study aims: Endoscopic pancreatic sphincterotomy is indispensable for many therapeutic endoscopic maneuvers, but is also associated with a higher risk of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). In this study, this subgroup of patients was investigated in order to identify risk factors and protective factors. Patients and methods: A retrospective chart review identified 572 endoscopic pancreatic sphincterotomies that met the inclusion criteria. Charts were examined for indications, endoscopic technique, and outcomes, including pancreatitis. Results: A total of 477 patients underwent 572 endoscopic pancreatic sphincterotomies during a 5-year period. Indications for sphincterotomy included chronic pancreatitis (n = 398), access for tissue sampling (n = 52), acute recurrent pancreatitis (n = 45), transpapillary drainage of a pancreatic pseudocyst (n = 32), precut access to the common bile duct (n = 29), and others (n = 16). Pancreatic duct drainage was performed in 69.1 % of the procedures (nasopancreatic catheter, n = 290, or pancreatic stent placement, n = 105). Post-ERCP pancreatitis occurred in 69 cases (12.1 %) and was severe in 10. The multivariate analysis identified female sex as being associated with a higher risk of pancreatitis, while an elevated C-reactive protein level, pancreatic ductal stones, sphincterotomy at only the major papilla, and pancreatic duct drainage with a nasopancreatic catheter or stent were associated with a lower risk. Conclusions: This large series of patients undergoing endoscopic pancreatic sphincterotomy provides further evidence that both patient characteristics and technical factors modify the risk profile for post-ERCP pancreatitis. In addition to providing further definition of which patients are at risk, it also suggests that pancreatic duct drainage is an independently significant protective maneuver.
References
1
Aronson N, Flamm C R, Bohn R L. et al .
Evidence-based assessment: patient, procedure, or operator factors associated with ERCP complications.
Gastrointest Endosc.
2002;
56 (6 Suppl)
S294-S302
2
Freeman M L, Disario J A, Nelson D B. et al .
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.
Gastrointest Endosc.
2001;
54
425-434
3
Loperfido S, Angelini G, Benedetti G. et al .
Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.
Gastrointest Endosc.
1998;
48
1-10
4
Masci E, Mariani A, Curioni S, Testoni P A.
Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
Endoscopy.
2003;
35
830-834
6
Aizawa T, Ueno N.
Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.
Gastrointest Endosc.
2001;
54
209-213
7
Fazel A, Quadri A, Catalano M F. et al .
Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.
Gastrointest Endosc.
2003;
57
291-294
8
Rashdan A, Fogel E L, McHenry Jr L . et al .
Improved stent characteristics for prophylaxis of post-ERCP pancreatitis.
Clin Gastroenterol Hepatol.
2004;
2
322-329
9
Smithline A, Silverman W, Rogers D. et al .
Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients.
Gastrointest Endosc.
1993;
39
652-657
11
Singh P, Das A, Isenberg G. et al .
Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.
Gastrointest Endosc.
2004;
60
544-550
12
Akashi R, Kiyozumi T, Jinnouchi K. et al .
Pancreatic sphincter precutting to gain selective access to the common bile duct: a series of 172 patients.
Endoscopy.
2004;
36
405-410
13
Kahaleh M, Tokar J, Mullick T. et al .
Prospective evaluation of pancreatic sphincterotomy as a precut technique for biliary cannulation.
Clin Gastroenterol Hepatol.
2004;
2
971-977
14
Devière J, Le Moine O, Van Laethem J L. et al .
Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
Gastroenterology.
2001;
120
498-505
15
Ell C, Rabenstein T, Schneider H T. et al .
Safety and efficacy of pancreatic sphincterotomy in chronic pancreatitis.
Gastrointest Endosc.
1998;
48
244-249
16
Heyries L, Barthet M, Delvasto C. et al .
Long-term results of endoscopic management of pancreas divisum with recurrent acute pancreatitis.
Gastrointest Endosc.
2002;
55
376-381
17
Jakobs R, Benz C, Leonhardt A. et al .
Pancreatic endoscopic sphincterotomy in patients with chronic pancreatitis: a single-center experience in 171 consecutive patients.
Endoscopy.
2002;
34
551-554
19
Okolo III P I, Pasricha P J, Kalloo A N.
What are the long-term results of endoscopic pancreatic sphincterotomy?.
Gastrointest Endosc.
2000;
52
15-19
20
Smits M E, Rauws E A, Tytgat G N, Huibregtse K.
Endoscopic treatment of pancreatic stones in patients with chronic pancreatitis.
Gastrointest Endosc.
1996;
43
556-560
21
Elton E, Howell D A, Parsons W G. et al .
Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique.
Gastrointest Endosc.
1998;
47
240-249
22
Cotton P B, Lehman G, Vennes J. et al .
Endoscopic sphincterotomy complications and their management: an attempt at consensus.
Gastrointest Endosc.
1991;
37
383-393
23
Bradley 3rd E L .
A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992.
Arch Surg.
1993;
128
586-590
24
Cremer M, Toussaint J, Hermanus A. et al .
Primary chronic pancreatitis: a classification based on endoscopic pancreatography (in French).
Acta Gastroenterol Belg.
1976;
39
522-546
26
Delhaye M, Arvanitakis M, Verset G. et al .
Long-term clinical outcome after endoscopic pancreatic ductal drainage for patients with painful chronic pancreatitis.
Clin Gastroenterol Hepatol.
2004;
2
1096-1106
